Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07574749
Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic EfficacyFudan UniversityRecruiting
NCT07574749Recruiting
—
Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs)...Fudan University
NCT07575399
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)AmgenNot Yet RecruitingPhase 3
NCT07575399Not Yet Recruiting
Phase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Rece...Amgen
NCT07574593
NORM-HF Pivotal StudyBaim Institute for Clinical ResearchNot Yet RecruitingNot Applicable
NCT07575854
A Study of Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal CancerCentre Georges Francois LeclercNot Yet RecruitingNot Applicable
NCT07575854Not Yet Recruiting
Not Applicable
A Study of Selective Internal Radiation Therapy for the Management of Chemothera...Centre Georges Francois L...
NCT07574606
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla Covered With Buccal Fat Pad vs. Palatal Pedicle FlapFuture University in EgyptRecruitingNot Applicable
NCT07574606Recruiting
Not Applicable
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla...Future University in Egyp...
NCT07575529
DORA - An Exploratory, Interventional Study Using Digital Health Tools and OneBiome to Explore the Impact of the Consumption of Senior Milk Powder Containing Synbiotics on the Gut micRobiome in Healthy Aging IndividualsDanone Asia Pacific Holdings Pte, Ltd.Not Yet RecruitingNot Applicable
NCT07575529Not Yet Recruiting
Not Applicable
DORA - An Exploratory, Interventional Study Using Digital Health Tools and OneBi...Danone Asia Pacific Holdi...
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07576959
Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori EradicationNational Taiwan University HospitalRecruitingPhase 3
NCT07576959Recruiting
Phase 3
Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori EradicationNational Taiwan Universit...
NCT07576530
HOLA Intervention PilotRutgers, The State University of New JerseyNot Yet RecruitingNot Applicable
NCT07574853
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodontal Bone Tissue RegenerationThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07574853Not Yet Recruiting
Not Applicable
Study on Silk Fibroin-Reinforced Collagen-Based Composite Membrane for Periodont...The First Affiliated Hosp...
NCT07576543
Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After SurgeryFujian Medical University Union HospitalNot Yet RecruitingPhase 4
NCT07576543Not Yet Recruiting
Phase 4
Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Co...Fujian Medical University...
NCT07574957
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNAAssistance Publique - Hôpitaux de ParisNot Yet Recruiting
NCT07574957Not Yet Recruiting
—
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of...Assistance Publique - Hôp...
NCT07576998
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic Subdural Hematoma IDE TrialMicrovention-Terumo, Inc.Not Yet RecruitingNot Applicable
NCT07576998Not Yet Recruiting
Not Applicable
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic S...Microvention-Terumo, Inc.
NCT07575594
The Use of White Noise and Quiet Time During LaborIstanbul University - CerrahpasaCompleted
NCT07575152
Estimation of Fetal Weight by Measuring Abdominal Circumference, Abdominal Subcutaneous Soft Tissue Thickness, Femur Length and Mid-thigh Soft Tissue Thickness: Cross Sectional Study.Assiut UniversityNot Yet Recruiting
NCT07575152Not Yet Recruiting
—
Estimation of Fetal Weight by Measuring Abdominal Circumference, Abdominal Subcu...Assiut University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07575256
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion FracturesBeijing Tsinghua Chang Gung HospitalNot Yet RecruitingNot Applicable
NCT07575256Not Yet Recruiting
Not Applicable
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior...Beijing Tsinghua Chang Gu...
NCT07574541
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active SurveillanceNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07574541Not Yet Recruiting
Phase 2
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno)...National Cancer Institute...
NCT07576803
Hydrodissection With Neuroprolotherapy Versus Open Release for Carpal Tunnel SyndromeUniversidade Federal de PernambucoNot Yet RecruitingNot Applicable
NCT07576803Not Yet Recruiting
Not Applicable
Hydrodissection With Neuroprolotherapy Versus Open Release for Carpal Tunnel Syn...Universidade Federal de P...
Result Breakdown
Not yet recruiting15 (75%)
Recruiting4 (20%)
Completed1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 33 (15%)
Phase 11 (5%)
Phase 41 (5%)
Phase 21 (5%)